NVS
Novartis AG
NYSE · Healthcare · Drug Manufacturers - General · CH
$159.70
−2.08%Forward multiples
Based on analyst estimates
- P/E forward
- 17.08x
- P/E 2026E
- 18.24x
- P/E 2027E
- 16.35x
- P/E 2028E
- 14.80x
- P/S forward
- 5.14x
Trailing multiples
Trailing twelve months
- P/E TTM
- 23.98x
- PEG TTM
- 0.59x
- Price / book
- 7.31x
- Price / sales
- 5.46x
- Price / cash flow
- 16.51x
Enterprise value
- Enterprise value
- $345.3B
- EV / sales
- 6.21x
- EV / EBITDA
- 15.51x
- EV / EBIT
- 20.32x
- Market cap
- $303.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026